Michael Lee Stallard

SEPTEMBER 16, 2015

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. You can see evidence of Pfizer’s commitment in Ian Read’s letter to stakeholders the year after he became CEO: In 2011, we thoroughly explored what our culture is and how it needs to evolve. Pfizer people care.

Ethics 150

Ethics Pharmaceuticals Globalization Commitment 150

Coaching Tip

MARCH 15, 2011

All it takes is the desire to be innovative and creative in tackling a problem. Despite all the talk about the competitiveness of the global economy , the fact remains that for almost every rational human being on the planet, America remains the envy of the world and the land of opportunity. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). Copyright (c) 2011. Copyright 2007-2011 by StrategyDriven, Inc.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

JUNE 29, 2015

And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative. PE investors don’t typically invest in firms known for innovation. ” There were other limitations. .

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

DECEMBER 20, 2011

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. In both instances, the life-cycle management innovation involves using disintermediation to change how the customer interacts with the product. 30) of a blockbuster prescription drug. And both teach lessons that apply across many industries.

Disintermediation 15

Disintermediation Industry Pharmaceuticals Price 15